{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:48:30Z","timestamp":1787060910645,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,27]]},"DOI":"10.1097\/tp.0b013e318199c1c7","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T17:06:32Z","timestamp":1242925592000},"page":"795-802","source":"Crossref","is-referenced-by-count":101,"title":["Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation"],"prefix":"10.1097","volume":"87","author":[{"given":"Gerhard","family":"Opelz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"D\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: Evolution in practice and trends, 1994\u20132004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data.","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-6143.2007.01661.x","article-title":"One-year results with extended-release tacrolimus\/MMF, tacrolimus\/MMF and cyclosporine\/MMF in de novo kidney transplant recipients.","volume":"7","author":"Silva","year":"2007","journal-title":"Am J Transplant"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): A randomised trial.","volume":"364","author":"Remuzzi","year":"2004","journal-title":"Lancet"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1681\/ASN.2006101153","article-title":"Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: The MYSS follow-up randomized, controlled clinical trial.","volume":"18","author":"Remuzzi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1600-6143.2007.01759.x","article-title":"Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome.","volume":"7","author":"Mcdonald","year":"2007","journal-title":"Am J Transplant"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/TP.0b013e3181661695","article-title":"Influence of time of rejection on long-term graft survival in renal transplantation.","volume":"85","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.TP.0000041722.34000.21","article-title":"Early versus late acute rejection episodes in renal transplantation.","volume":"75","author":"SijpkensYW, Doxiadis","year":"2003","journal-title":"Transplantation"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.00640805","article-title":"Role of maintenance immunosuppressive regimen in kidney transplant outcome.","volume":"1","author":"Goldfarb-Rumyantzev","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1097\/01.ASN.0000095250.92361.D5","article-title":"Long-term graft survival with Neoral and tacrolimus: A paired kidney analysis.","volume":"14","author":"Kaplan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.tp.0000184842.01686.CA","article-title":"Renal graft survival and calcineurin inhibitor.","volume":"80","author":"Woodward","year":"2005","journal-title":"Transplantation"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/01.TP.0000090865.20886.B7","article-title":"Three year posttransplant survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple drug regimen.","volume":"76","author":"Irish","year":"2003","journal-title":"Transplantation"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.TP.0000079965.62765.1A","article-title":"Graft survival following living-donor renal transplantation: A comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.","volume":"76","author":"Bunnapradist","year":"2003","journal-title":"Transplantation"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00007890-200102150-00010","article-title":"Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.","volume":"71","author":"Meier-Kriesche","year":"2001","journal-title":"Transplantation"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis.","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States.","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among US wait-listed and transplant renal allograft recipients.","volume":"3","author":"Woodward","year":"2003","journal-title":"Am J Transplant"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/ndt\/14.10.2364","article-title":"An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.","volume":"14","author":"Bates","year":"1999","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200903270-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:48:41Z","timestamp":1739101721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200903270-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318199c1c7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161565.623119","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3,27]]}}}